The Research and Development team at Dynavax Technologies focuses on advancing the development of novel vaccines through innovative research, effective process development, and comprehensive project management. Collaborating across various functions, including drug substance development and clinical supplies management, the team works to ensure the successful transition of vaccine candidates from discovery through to commercialization, while also engaging in medical affairs and external partnerships to enhance research outcomes.
Aashish Bhatia
Executive Director, CMC Projec...
Amy Gonzales
Associate Director, Clinical S...
Benjamin Wizel
Senior Director, Head Of Exter...
Courtney Andujar
Director, Vaccine Sales - Reta...
David S. Chen
Director, R&d And Global Opera...
Friedhelm Helling
VP, Process Development & Manu...
Maureen Urban
Executive Director, Process De...
Patricia Novy
VP, Medical Affairs
Seth Thomas
Director, Drug Substance Devel...